To evaluate the combination of transbronchial biopsy (TBB) using endobronchial ultrasonography with a guide sheath (EBUS-GS) and positron emission tomography with fluorodeoxyglucose (FDG-PET) for the diagnosis of small peripheral pulmonary lesions (PPLs) ≤30 mm in mean diameter. A total of 74 PPLs (69.2%) were diagnosed by TBB using EBUS-GS with X-ray fluoroscopy. Diagnostic yield by FDG-PET was 78.5% for the 107 PPLs examined. Diagnostic yield with the combination of TBB using EBUS-GS and FDG-PET (90.7%) was significantly higher compared with that for each procedure alone. A significant increment in diagnostic yield with this combination was seen for PPLs >20 mm and ≤30 mm and for malignant lesions. Combination of TBB using EBUS-GS and FDG-PET is useful for the diagnosis of small PPLs.
Summary
To evaluate the combination of transbronchial biopsy (TBB) using endobronchial ultrasonography with a guide sheath (EBUS-GS) and positron emission tomography with fluorodeoxyglucose (FDG-PET) for the diagnosis of small peripheral pulmonary lesions (PPLs) ≤30 mm in mean diameter. A total of 74 PPLs (69.2%) were diagnosed by TBB using EBUS-GS with X-ray fluoroscopy. Diagnostic yield by FDG-PET was 78.5% for the 107 PPLs examined. Diagnostic yield with the combination of TBB using EBUS-GS and FDG-PET (90.7%) was significantly higher compared with that for each procedure alone. A significant increment in diagnostic yield with this combination was seen for PPLs >20 mm and ≤30 mm and for malignant lesions. Combination of TBB using EBUS-GS and FDG-PET is useful for the diagnosis of small PPLs.
Introduction
Various procedures have been developed to diagnose peripheral pulmonary lesions (PPLs). Transbronchial biopsy (TBB) procedures, which use a bronchoscope under fluoroscopic guidance, have been performed since the 1970s, with a diagnostic accuracy of 36-86% [1] [2] [3] [4] [5] .
This diagnostic accuracy is influenced by lesion size. Schreiber et al.
reported in a systematic review that the diagnostic accuracy for lesions <20 mm was 33% [1] . Other studies have found a diagnostic accuracy of 35-50% for benign lesions, lower than that for malignant lesions [2] [3] [4] [5] .
Currently, small-caliber radial-type ultrasound probes can be used for the clinical application of ultrasonography to examine tracheal-bronchial lesions. Endobronchial ultrasonography (EBUS) has been used for imaging guidance for TBB of PPLs [6, 7] . Furthermore, Kurimoto et al. and our own preliminary study have shown the feasibility and effectiveness of TBB using EBUS with a guide sheath (EBUS-GS) [14] [15] [16] [17] .
These reports led us to the idea that the combination of TBB using EBUS-GS and FDG-PET might improve diagnostic yields for PPLs. The present study therefore evaluated a combination method for the diagnosis of small PPLs ≤30 mm in diameter.
MATERIALS AND METHODS

Patients
Medical records of 107 patients with 107 small PPLs (mean diameter, All chest computed tomography (CT) images were reviewed, and mean diameters of PPLs were recorded. This study was approved by the Internal Review Board at our institution. All patients had provided written informed consent to undergo the procedures described below.
TBB using EBUS-GS
TBB using EBUS-GS was performed as described previously When a definitive diagnosis was not obtained by TBB using -8 -EBUS-GS, the patient underwent other procedures (e.g., video-assisted thoracoscopic surgery (VATS), percutaneous needle biopsy) or clinical and radiological follow-up examinations to confirm diagnosis of the PPL.
FDG-PET
FDG-PET was performed 60 min after injection of 4.5 MBq/kg body weight of fluorodeoxyglucose using an EXACT 47 scanner (Siemens, Munich, Germany). Patients had to fast for ≥6 h prior to FDG administration. Scanning itself encompassed an emission scan (2 min) and transmission (3 min) using rotating 68 Ge-68 Ga rod sources. Scans were reconstructed with the ordered subsets expectation maximization algorithm. FDG uptake was evaluated using the maximum standardized uptake value (SUV max ). FDG-PET was examined within 4weeks before TBB using EBUS-GS.
Statistical Analysis
The data that SUV max and diagnostic yields by TBB with EBUS-GS alone and FDG-PET alone were analyzed using Pearson χ 2 test. The diagnostic yields by combining TBB using EBUS-GS and FDG-PET were analyzed using
McNemar test. Statistical software (SPSS version 11.0.1; Chicago, IL) was used for all analyses. Statistical significance was established at the p < 0.05 level.
RESULTS
Diagnostic yield by TBB using EBUS-GS
Mean (±standard deviation) diameter of the PPLs was 21.7 ±6.1 mm (range, 9.5-30 mm). Of the 107 PPLs examined, a total of 92 PPLs (86.0%) were detected by EBUS. Definitive diagnosis was established for 74 PPLs (69.2%) by TBB using EBUS-GS (Table 1) . Diagnostic yields for PPLs ≤20 mm and for PPLs >20 mm and ≤30 mm in mean diameter by TBB using EBUS-GS were 54.5% (24 of 44 PPLs) and 76.2% (48 of 63 PPLs), respectively. The diagnostic yield for PPLs ≤20 mm was significantly lower than that for PPLs >20 mm and ≤30 mm (p<0.05). The diagnostic yield tended to be lower for benign disease (50.0%) than for malignant disease (72.5%), but this difference was not statistically significant.
Diagnostic yield by FDG-PET
In all PPLs, mean SUV max for FDG-PET was 4.2 ±2.9. A significant difference in SUV max was seen between malignant disease (4.5 ±3.0) and benign disease (2.5 ±1.6; p<0.01). With malignant disease, a significant difference in SUV max was seen between PPLs ≤20 mm (2.9
±1.4) and PPLs >20 mm and ≤30 mm (5.5 ±3.2; p<0.01). Conversely, with benign disease, no significant differences were seen according to tumor size (Table 2) .
To determine a cut-off value of SUV max for diagnosing pulmonary malignancy with FDG-PET, we analyzed the receiver operating characteristics (ROC) curve of SUV max in all PPLs. The ROC curve
showed that a cut-off value of 2.0 would provide the highest sensitivity and specificity (Fig. 1) . We then selected a cut-off value of 2.0 of SUV max for the following analysis in this study.
When using this criterion, diagnostic yield was 78.5% for the 107
PPLs examined. Diagnostic yields by FDG-PET of PPLs ≤20 mm and PPLs >20 mm and ≤30 mm were 70.5% (31 of 44 PPLs) and 84.1% (53 of 63 PPLs), respectively. Diagnostic yield was significantly lower for PPLs ≤20 mm than for PPLs >20 mm and ≤30 mm (p<0.01). Diagnostic yield was also significantly lower for benign disease (56.3%) than for malignant disease (82.4%; p<0.01).
Diagnostic yield with combination of TBB using EBUS-GS and
FDG-PET
Next, the diagnostic yield by combining TBB using EBUS-GS and FDG-PET was evaluated (Table 3 ; results for each method are also shown). Diagnostic yield with the combination of TBB using EBUS-GS and FDG-PET was 90.7% for the 107 PPLs examined. In addition, sensitivity, specificity, positive predictive value, and negative predictive value for combination of TBB using EBUS-GS and FDG-PET were 94.5%, 68.8%, 94.5%, and 68.8%, respectively. According to size, diagnostic yield for PPLs >20 mm and ≤30 mm in mean diameter reached 96.8%, while diagnostic yield for PPLs ≤20 mm was 81.8%. When restricted to malignant diseases, diagnostic yield with the combination of techniques (94.5%) was still significantly higher than those for each procedure alone (72.5% by TBB with EBUS-GS alone; 82.4% by FDG-PET alone).
Diagnostic yield for malignant diseases with PPLs >20 mm and ≤30 mm using the combination method reached 100%. Conversely, no significant differences in diagnostic yields were seen for benign disease, although diagnostic yield with the combination method (68.8%) tended to be higher than those for each procedure alone (50.0% for EBUS-GS alone;
56.3% for FDG-PET alone).
Non-diagnostic lesions by both TBB using EBUS-GS and
FDG-PET
Even after combining TBB using EBUS-GS with FDG-PET, diagnostic yields did not reach 100%, and 10 PPLs were not diagnosed even by the combination method. These 10 PPLs comprised 5 malignant lesions 
Representative cases
The first case involved a 61-year-old man presenting with a small PPL 10 mm in mean diameter in the left segment 4 (Fig. 2) . On FDG-PET, slight FDG uptake was observed in the left upper lobe (SUV max , 1.45).
The PPL was diagnosed as lung adenocarcinoma. This case was representative of a false-negative finding on FDG-PET.
The second case involved a 74-year-old man with chronic obstructive pulmonary disease (COPD) presenting with a small PPL of 15 mm in mean diameter in segment 6 of the right lung (Fig. 3) . On FDG-PET, high uptake was seen in the right lower lobe (SUV max , 4.52). TBB using EBUS-GS was not diagnostic, while partial resection by VATS revealed squamous cell carcinoma. This case was representative of cases in which FDG-PET was useful for the diagnosis of malignant disease, but TBB with EBUS-GS was not.
DISCUSSION
The present study combined TBB using EBUS-GS with FDG-PET for the diagnosis of small PPLs ≤30 mm in mean diameter. This is the first report that shows the usefulness of combination of EBUS-GS and FDG-PET for pulmonary peripheral lesions. As a result, diagnostic yield with this combination was >90%, significantly higher than with each procedure alone. We have provided novel, important evidence that the combination of TBB using EBUS-GS and FDG-PET is useful in the diagnosis of small PPLs. Chhajed et al. have already reported the usefulness of combining TBB with FDG-PET in the diagnosis of small PPLs ≤30 mm in mean diameter [19] . However, they used conventional bronchoscopy, and the diagnostic yield of bronchoscopy was 53%, including 8% for endobronchial lesions. As TBB with EBUS-GS is obviously superior to conventional bronchoscopy, particularly for the diagnosis of smaller PPLs [8-13], our results will contribute to the development of diagnostic procedures for small PPLs.
Some previous reports have used a cut-off SUV max of 2.5 [15, 19] , but no obvious validation has been provided for this value, particularly for small PPLs ≤ 30 mm in mean diameter. In the present study, we selected a cut-off SUV max of 2.0, as the ROC curve of SUV max for all PPLs showed that this value offered higher sensitivity and specificity than 2.5. Bryant et al. reported that in small PPLs ≤25 mm, 24% of nodules with SUV max ≤2.5 were malignant [20] . When using a cut-off of 2.0, diagnostic yield by FDG-PET was 78.5% for the 107 PPLs examined (82.4% for malignant, 56.3% for benign), similar to the findings of previous studies [21] . Determining the optimal cut-off value for FDG-PET in each study using reliable methods such as ROC curves is important.
However, FDG-PET is not always diagnostic, particularly for small PPLs. Small malignant lesions ≤30 mm in mean diameter could show lower FDG uptake than larger malignant tumors, due to partial-volume effects [22] . Malignant lesions such as well-differentiated adenocarcinoma and bronchiolo-alveolar carcinoma are frequently missed by FDG-PET due to low glucose metabolism [12] [13] [14] [15] 17, 18] . In this study, the 44 adenocarcinomas included 14 PPLs that were false-negative on FDG-PET, and pathological review showed that these The limitations of the combination method must be kept in mind, particularly in small PPLs ≤20 mm. The present study encountered no complications associated with TBB using EBUS-GS or FDG-PET that required hospitalization.
Conclusion
In conclusion, based on our retrospective analysis, the combination of TBB with EBUS-GS and FDG-PET increased diagnostic yield to >90%, representing a useful method for the diagnosis of small PPLs ≤30 mm. In cases where neither TBB using EBUS-GS nor FDG-PET is diagnostic, the combination strategy supports the decision of the physician as to whether more invasive procedures or clinical and radiological follow-up are required for the management of PPLs. 
